» Articles » PMID: 7126260

On the Binding of a 3-alpha-methylated Digitoxigenin-glucoside to Ouabain Receptors in Heart Muscle Homogenate

Overview
Date 1982 Aug 1
PMID 7126260
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

3-alpha-Methyl substituted digitoxigenin-3-beta-glucoside (methyl-dtg-gluc) displays unusual features, e.g. a high dissociation rate constant from its binding site leading to rapid reversibility of the inotropic and toxic effects, and a flat dose-response curve attaining higher inotropic maxima thus indicating an increased therapeutic index in animal experiments. In order to check whether or not methyl-dtg-gluc is specifically bound to the same receptors as classic cardiac glycosides we compared binding of ouabain and of methyl-dtg-gluc to guinea-pig heart muscle homogenate. For both compounds specific binding required the addition of ATP (2.5 mM). The binding curve for ouabain yielded half maximum binding at 1.3 x 10(-7) M and maximum number of binding sites of 6 pmole/mg protein; the corresponding values for methyl-dtg-gluc amounted to 1.4 x 10(-6) M and 6 pmole/mg protein, respectively. A mutual competition could be demonstrated between the two compounds. Since the provided data are equilibrium values they do not exclude higher turnover rates of methyl-dtg-gluc in comparison with ouabain at a given glycoside-ATPase complex concentration which can be expected from the fast dissociation rate constant of the methyl-dtg-gluc-ATPase complex. The results are briefly discussed with respect to the molecular mole of action of cardiac glycosides.

Citing Articles

Differentiation between isoforms of Na+/K+-transporting atpase from human and guinea-pig muscle through use of digitalis derivatives as analytical probes.

Schon R, Weiland J, MEGGES R, Repke K Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(3):282-92.

PMID: 7609782 DOI: 10.1007/BF00233248.


Electrophysiological studies of some semisynthetic cardiac glycoside derivatives in isolated papillary muscle of the guinea-pig.

LULLMANN H, Niehus U, Pulss W, Ravens U Br J Pharmacol. 1983; 79(3):755-64.

PMID: 6652355 PMC: 2044912. DOI: 10.1111/j.1476-5381.1983.tb10014.x.